Zusammenfassung
Die Bedeutung einer ausreichenden Versorgung von jungen Frauen im reproduktionsfähigen Alter und von Schwangere ist mittlerweile Teil des Allgemeinwissens, und die Rate an Neuralrohrdefekten konnte effizient gesenkt werden. Doch damit ist die Bedeutung dieses wichtigen Spurenelementes durchaus nicht erschöpft. Thrombophile Zustände in der Schwangerschaft führen zu Plazentationsstörungen mit gehäuften Aborten, fetaler Wachstumsverzögerung und erhöhen das Risiko für Gestosen. Dass hier ein Stoffwechseldefekt im Folsäuremetabolismus eine wichtige Rolle spielt, ist allerdings nur wenig bekannt und erforscht. Der Beitrag beleuchtet neben Grundlagen des Folsäurestoffwechsels auch dessen klinische Bedeutung über die Neuralrohrdefekte hinaus und zeigt neue Ansätze zur optimalen Risikominderung von Schwangerschaftskomplikationen bei Folsäurestoffwechseldefekten auf.
Abstract
Sufficient intake of folic acid is an essential component of the nutrition of young fertile women and during pregnancy. The incidence of neural tube defects can be reduced dramatically; however, further meaningful aspects of folic acid function should be mentioned. Thrombophilic conditions during pregnancy result in placental disorders with recurrent miscarriage, intrauterine growth retardation and preeclampsia. Defects in folic acid metabolic pathways seem to play an important role in the development of these complications. This article focuses on the basic principles of folic acid metabolic pathways and polymorphisms and the clinical importance in the context of complications during pregnancy. New insights into this topic provide optimal risk reduction and patient care in folic acid metabolic defects.
Literatur
Bönstrup A (2007) Folat und Folsäure – Herausforderungen für die Praxis. Ernahrungsumschau 9:538–544
Shane B (2010) Folate chemistry and metabolism. In: Bailey LB (eds) Folate in health and disease, 2. edn. Taylor & Francis, Boca Raton, pp 1–24
IOM (Institute of Medicine) (2000) Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin and choline. National Academy, Washington/DC, pp 196–305
Obeid R, Holzgreve W, Pietrzik K (2013) Is 5-methyltetrahydrofolate an alternative to folic acid in the prevention of neural tube defects? J Perinat Med 41(5):469–483
Deutsche Gesellschaft für Ernährung e. V. (2013) Referenzwerte für die Nährstoffzufuhr: Folat. Neuer, Neustadt a.d. Weinstr. Umschau, S 127–151. (5. korr. Nachdruck)
Carmel R (2006) Folic Acid. In: Shils M, Shike M, Ross AC (eds) Modern nutrition in health and disease, 10. edn. Lippincott Williams & Wilkins, Baltimore, pp 470–481
Doenecke D, Koolman J, Fuchs G, Gerok W (2005) Karlsons Biochemie und Pathobiochemie, 15. Aufl. Thieme, Stuttgart, S 88–89
Owczarek D, Cibor D, Salapa K et al (2014) Homocysteine in patients with inflammatory bowel diseases. Przegl Lek 71(4):189–192
Czeizel AE, Dudas I (1992) Prevention of the first occurrence of neural-tube defects by periconeptional vitamin supplementation. N Engl J Med 327:1832–1835
Scholl TO, Johnson WG (2000) Folic acid: Influence on the outcome of pregnancy. Am J Clin Nutr 71(5):1295–1303
Bukowski R, Malone FD, Porter FT et al (2009) Preconception folate supplementation and the risk of spontaneous preterm birth: prospective cohort study. PLoS Med 6(5):e10000061
Gaskins AJ, Rich-Edwards JW, Hauser R et al (2014) Maternal prepregnancy folate intake and the risk of spontaneous abortion and stillbirth. Obstet Gynecol 124(1):23–31
Lassi ZS, Salam RA, Haider BA et al (2013) Folic acid supplementation during pregnancy for maternal health and pregnancy outcomes. Cochrane Database Syst Rev 3:CD006896
Mavrogenis S, Urban R, Czeizel AE, Acs N (2014) Possible preventive effect of high doses of folic acid for isolated hypospadias: a national population-based case-control study. Am J Med Genet A 9999:1–7
Shaw GM, Lammer EJ, Wassermann CR et al (1995) Risks of orafacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet 346:393–396
Ströhle A, Wolters M, Willer J et al (2014) Mikronährstoffe in den verschiedenen Lebensphasen der Frau (Teil 3) – Schwangerschaft: Nahrung für einen optimalen Start ins Leben. Gyne 5:33–39
Ohrvik VE, Witthoft CM (2011) Human folate bioavailability. Nutrients 3:475–490
Tahler CJ (2014) Folate Metabolism and Human Reproduction. Geburtsh Frauenheilk 74:845–851
Idali F, Zareii S, Mohammad-Zadeh A et al (2012) Plasminogen activator inhibitor 1 and methylenetetrahydrofolate reductase gene mutations in Iranian women with polycystic ovary syndrome. Am J Reprod Immunol 68(5):400–407
Gruson D (2003) Cardiovascular diseases and homocysteine, a short summary of a long story. J Int Clin Chem 14:3
Beynum IM van et al (1999) Hyperhomocysteinaemia: a risk factor for ischemic stroke in children. Circulation 99:2070–2072
Heckey SE, Curry CJ, Toriello HV (2013) ACMG practice guideline: lack of evidence for MTHFR polymorphism testing. Genet Med 15(2):153–156
Nelen WL (2001) Hyperhomocysteinaemia and human reproduction. Clin Chem Lab Med 39(8):758–763
Fatini C, Gensini F, Battaglini B et al (2000) Angiotensin-converting enzyme DD genotype, angiotensin type 1 receptor CC genotype, and hyperhomocysteinemia increase first-trimester fetal-loss susceptibility. Blood Coagul Fibrinolysis 11(7):657–662
Lissak A, Sharon A, Fruchter O et al (1999) Polymorphism for mutation of cytosine to thymine at location 677 in the methylenetetrahydrofolate reductase gene is associated with recurrent early fetal loss. Am J Obstet Gynecol 181:126–130
Martinelli I, Taioli E, Cetin I et al (2000) Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med 343:1015–1018
Nelen WLDM, Molen EF van der, Blom HJ et al (1997) Recurrent early pregnancy loss and genetic-related disturbances in folate and homocysteine metabolism. Br J Hosp Med 58:511–513
Vollset SE, Refsum H, Irgens LM et al (2000) Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine Study. Am J Clin Nutr 71:962–968
Luxembourg B, Lindhoff-Last E (2007) Genomische Diagnostik thrombophiler Gerinnungsstörungen bei Frauen. Hamostaseologie 27(1):22–31
Robertson L, Wu O, Langhorne P et al (2005) For the Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thrombophilia in pregnancy: a systematic review. Br J Haematol 132:171–196
Yadav U, Kumar P, Yadav SK et al (2014) Polymorphisms in folate metabolism genes as maternal risk factor for neural tube defects: an updated meta-analysis. Metab Brain Dis (PMID: 25005003)
Qublan HS, Eid SS, Ababneh HA et al (2006) Acquired and inherited thrombophilia: implication in recurrent IVF and embryo transfer failure. Hum Reprod 21:2694–2698
Nelen WL, Blom HJ, Thomas CM et al (2008) Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages. J Nutr 128:1336–1341
Einhaltung ethischer Richtlinien
Interessenkonflikt. E. Edeler und A. Heubner geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Elisabeth Edeler und Antonia Heubner teilen die Erstautorenschaft.
Rights and permissions
About this article
Cite this article
Edeler, E., Heubner, A., Kimmig, R. et al. Update Folsäurestoffwechsel. Gynäkologe 48, 159–163 (2015). https://doi.org/10.1007/s00129-014-3516-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00129-014-3516-8